ArticleScientific reports2026
Design and classify innovative antimicrobial and dual- and multi-functional peptides using generative artificial intelligence.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Antimicrobial resistance is a growing global crisis, where antimicrobial peptides (AMPs) have emerged as promising alternatives to conventional antibiotics due to their unique mechanisms of action. However, traditional peptide design approaches, especially when designing multi-functional peptides, are often costly and time-consuming. This study explores the potential of ChatGPT as a prompt-based tool used without additional fine-tuning, for the classification and design of peptides with varying degrees of functional capabilities. We optimized the AMP design prompts by incorporating relevant information and refining them to design multi-functional peptides. For peptide classification, representative examples of positive and negative sequences were sourced from databases specific to each functionality, and a small exploratory set (10 positive sequences and 10 negative sequences) from the respective databases were randomly selected. In this preliminary evaluation, ChatGPT designed single- and dual-functional peptides with a promising apparent performance (accuracy > 0.9) and a decreased performance for triple- and quadruple-functional peptides (accuracy of 0.8) based on in silico testing. Additionally, ChatGPT showed promising preliminary results in classifying peptides with antimicrobial, non-hemolytic, cell-penetrating, and anticancer properties. Incorporating in-context example sequences significantly improved its classification performance. This work provides a proof-of-concept study of using a generative artificial intelligence tool for classification and multi-functional peptide design. While experimental validation is required, these findings suggest that accessible, non-coding Large Language Model approaches may support early-stage in silico peptide discovery that may be used in combination with existing computational tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.